A refined estimate of the lifetime cost of pelvic inflammatory disease

被引:4
作者
Rein, DB
Gift, TL
机构
[1] RTI Int, Div Hlth Econ Res, Atlanta, GA 30341 USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
关键词
D O I
10.1097/00007435-200405000-00013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:325 / 325
页数:1
相关论文
共 5 条
[1]   Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis [J].
Magid, D ;
Douglas, JM ;
Schwartz, JS .
ANNALS OF INTERNAL MEDICINE, 1996, 124 (04) :389-+
[2]   Direct medical cost of pelvic inflammatory disease and its sequelae: Decreasing, but still substantial [J].
Rein, DB ;
Kassler, WJ ;
Irwin, KL ;
Rabiee, L .
OBSTETRICS AND GYNECOLOGY, 2000, 95 (03) :397-402
[3]  
Stratton KR, 2000, Vaccines for the 21st century: a tool for decisionmaking in vaccines for the 21st century: a tool for decisionmaking
[4]   COST OF AND PAYMENT SOURCE FOR PELVIC INFLAMMATORY DISEASE - TRENDS AND PROJECTIONS, 1983 THROUGH 2000 [J].
WASHINGTON, AE ;
KATZ, P .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (18) :2565-2569
[5]   A refined estimate of the average lifetime cost of pelvic inflammatory disease [J].
Yeh, JM ;
Hook, EW ;
Goldie, SJ .
SEXUALLY TRANSMITTED DISEASES, 2003, 30 (05) :369-378